{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T08:04:40Z","timestamp":1793865880123,"version":"4.6.1"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004681","name":"Higher Education Commission Pakistan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004681","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010139","name":"Lahore University of Management Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.vaccine.2025.127029","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T09:59:25Z","timestamp":1742723965000},"page":"127029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Humoral immune response to 10-valent pneumococcal conjugate vaccine (PCV10) in individuals with type 2 diabetes mellitus"],"prefix":"10.1016","volume":"55","author":[{"given":"Izaz","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozina","family":"Arshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal Bin","family":"Younis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaper","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.vaccine.2025.127029_bb0005","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/dme.12260","article-title":"Risk of pneumonia and pneumococcal disease in people hospitalized with diabetes mellitus: English record-linkage studies","volume":"30","author":"Seminog","year":"2013","journal-title":"Diabet Med"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127029_bb0010","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.2337\/dc06-2417","article-title":"Type 2 diabetes and pneumonia outcomes: a population-based cohort study","volume":"30","author":"Kornum","year":"2007","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127029_bb0015","first-page":"17","article-title":"The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England","volume":"65","author":"Van Hoek","year":"2012","journal-title":"J Inf Secur"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127029_bb0020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/431521","article-title":"The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults","volume":"192","author":"Kyaw","year":"2005","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127029_bb0025","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s15010-018-1169-6","article-title":"Diabetes was the only comorbid condition associated with mortality of invasive pneumococcal infection in ICU patients: a multicenter observational study from the Outcomerea research group","volume":"46","author":"Garrouste-Orgeas","year":"2018","journal-title":"Infection"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127029_bb0030","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"Rao Kondapally Seshasai","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127029_bb0035","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.amepre.2018.01.033","article-title":"Pneumococcal vaccine coverage in adults aged 19\u201364 years, newly diagnosed with chronic conditions in the US","volume":"54","author":"Petigara","year":"2018","journal-title":"Am J Prev Med"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127029_bb0040","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1136\/thoraxjnl-2015-206780","article-title":"Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and\/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease","volume":"70","author":"Torres","year":"2015","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127029_bb0045","first-page":"156","article-title":"Recommended immunization schedule for children and adolescents aged 18 years or younger, United States, 2018","volume":"67","author":"Control, C.F.D. and Prevention","year":"2018","journal-title":"Ctr Dis Control Prev"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127029_bb0050","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.2337\/dc08-0138","article-title":"Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study","volume":"31","author":"Kornum","year":"2008","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127029_bb0055","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1128\/CVI.00268-12","article-title":"Impaired function of antibodies to pneumococcal surface protein a but not to capsular polysaccharide in Mexican American adults with type 2 diabetes mellitus","volume":"19","author":"Mathews","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127029_bb0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.trsl.2013.07.005","article-title":"Impaired CD4+ and T-helper 17 cell memory response to Streptococcus pneumoniae is associated with elevated glucose and percent glycated hemoglobin A1c in Mexican Americans with type 2 diabetes mellitus","volume":"163","author":"Martinez","year":"2014","journal-title":"Transl Res"},{"issue":"1582","key":"10.1016\/j.vaccine.2025.127029_bb0065","first-page":"2020","article-title":"The effects of type 2 diabetes mellitus on organ metabolism and the immune system","volume":"11","author":"Daryabor","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.127029_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.vaccine.2025.127029_bb0075","series-title":"Vaccine coverage amongst adult Canadians: results from the 2012 adult National Immunization Coverage (aNIC) survey","author":"Immunization","year":"2019"},{"key":"10.1016\/j.vaccine.2025.127029_bb0080","first-page":"69","article-title":"Pneumococcal and seasonal influenza vaccination among elderly patients with diabetes","author":"Gorska-Ciebiada","year":"2015","journal-title":"Advances in Hygiene & Experimental Medicine\/Postepy Higieny i Medycyny Doswiadczalnej"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127029_bb0085","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.4161\/hv.25826","article-title":"The effect of physicians' awareness on influenza and pneumococcal vaccination rates and correlates of vaccination in patients with diabetes in Turkey: an epidemiological study \u201cdiaVAX\u201d","volume":"9","author":"Satman","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127029_bb0090","first-page":"1","article-title":"Influenza and pneumococcal vaccination in patients with diabetes","volume":"2","author":"Koul","year":"2014","journal-title":"J Diabetol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127029_bb0095","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/21645515.2020.1756669","article-title":"Pneumococcal vaccination coverage in France by general practitioners in adults with a high risk of pneumococcal disease","volume":"17","author":"Kopp","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.127029_bb0100","series-title":"Pneumococcal vaccination in adults. U: UpToDate, bond S ur, UpToDate [internet]","first-page":"1","author":"Musher","year":"2017"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127029_bb0105","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2165\/11209330-000000000-00000","article-title":"Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed)","volume":"72","author":"Sanford","year":"2012","journal-title":"Drugs"},{"issue":"20","key":"10.1016\/j.vaccine.2025.127029_bb0110","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1001\/jama.1980.03310200050027","article-title":"Intact antibody response to pneumococcal capsular polysaccharides in uremia and diabetes","volume":"244","author":"Friedman","year":"1980","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127029_bb0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2337\/diab.30.2.119","article-title":"Pneumococcal immunization in adult diabetics","volume":"30","author":"Lederman","year":"1981","journal-title":"Diabetes"},{"issue":"23","key":"10.1016\/j.vaccine.2025.127029_bb0120","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1001\/jama.1980.03310230023016","article-title":"Antibody response to polyvalent pneumococcal polysaccharide vaccine in diabetics","volume":"244","author":"Beam","year":"1980","journal-title":"Jama"},{"key":"10.1016\/j.vaccine.2025.127029_bb0125","series-title":"Standards of medical care in diabetes\u20142018 abridged for primary care providers","author":"CARE","year":"2018"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127029_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1128\/CDLI.12.1.19-27.2005","article-title":"Use of HL-60 cell line to measure opsonic capacity of pneumococcal antibodies","volume":"12","author":"Fleck","year":"2005","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2025.127029_bb0135","series-title":"Protocol for multiplexed opsonophagocytic killing assay (UAB-MOPA) for antibodies against Streptococcus pneumoniae","author":"Nahm","year":"2013"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127029_bb0140","doi-asserted-by":"crossref","DOI":"10.1099\/mgen.0.000831","article-title":"Population genomics of pneumococcal carriage in South Africa following the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) immunization","volume":"8","author":"Javaid","year":"2022","journal-title":"Microbial Genomics"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127029_bb0145","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm0106-75","article-title":"Diabetes and obesity: the twin epidemics","volume":"12","author":"Smyth","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2025.127029_bb0150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00024677-200403040-00004","article-title":"Managing type 2 diabetes mellitus in patients with obesity","volume":"3","author":"Hauner","year":"2004","journal-title":"Treat Endocrinol"},{"issue":"43","key":"10.1016\/j.vaccine.2025.127029_bb0155","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1016\/j.vaccine.2008.07.071","article-title":"Pneumococcal vaccination in older adults induces antibodies with low opsonic capacity and reduced antibody potency","volume":"26","author":"Schenkein","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127029_bb0160","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/IAI.00768-10","article-title":"Older adults have a low capacity to opsonize pneumococci due to low IgM antibody response to pneumococcal vaccinations","volume":"79","author":"Park","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2025.127029_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.733566","article-title":"The dynamics of B cell aging in health and disease","volume":"12","author":"de Mol","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127029_bb0170","first-page":"361","article-title":"Aging impairs murine B cell differentiation and function in primary and secondary lymphoid tissues","volume":"2","author":"Frasca","year":"2011","journal-title":"Aging Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127029_bb0175","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1086\/520200","article-title":"Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity","volume":"29","author":"Romero-Steiner","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"19","key":"10.1016\/j.vaccine.2025.127029_bb0180","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1016\/j.vaccine.2007.01.119","article-title":"Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies","volume":"25","author":"Siber","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127029_bb0185","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/jcp.2006.041210","article-title":"Anti-pneumococcal antibody titre measurement: what useful information does it yield?","volume":"60","author":"Balmer","year":"2007","journal-title":"J Clin Pathol"},{"issue":"17","key":"10.1016\/j.vaccine.2025.127029_bb0190","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1016\/j.vaccine.2020.02.088","article-title":"Humoral response to a 13-valent pneumococcal conjugate vaccine in kidney transplant recipients","volume":"38","author":"Oesterreich","year":"2020","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127029_bb0195","doi-asserted-by":"crossref","first-page":"15376","DOI":"10.1038\/s41598-018-33735-x","article-title":"Outpacing the pneumococcus: antibody dynamics in the first few days following pneumococcal capsular antigen stimulation","volume":"8","author":"Kimaro Mlacha","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127029_bb0200","doi-asserted-by":"crossref","DOI":"10.1099\/mgen.0.001163","article-title":"Strain features of pneumococcal isolates in the pre-and post-PCV10 era in Pakistan","volume":"10","author":"Javaid","year":"2024","journal-title":"Microbial genomics"},{"key":"10.1016\/j.vaccine.2025.127029_bb0205","doi-asserted-by":"crossref","unstructured":"Paton, J.C. and C. Trappetti, Streptococcus pneumoniae capsular polysaccharide. Microbiology spectrum, 2019. 7(2): p. https:\/\/doi.org\/10.1128\/microbiolspec. gpp3-0019-2018.","DOI":"10.1128\/microbiolspec.GPP3-0019-2018"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127029_bb0210","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1128\/CVI.00402-10","article-title":"Impact of the conjugation method on the immunogenicity of Streptococcus pneumoniae serotype 19F polysaccharide in conjugate vaccines","volume":"18","author":"Poolman","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127029_bb0215","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1586\/14760584.2015.965160","article-title":"Predicting the impact of new pneumococcal conjugate vaccines: serotype composition is not enough","volume":"14","author":"Hausdorff","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.127029_bb0220","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1007\/BF00870139","article-title":"The immune response to influenza vaccination in diabetic patients","volume":"29","author":"Pozzilli","year":"1986","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127029_bb0225","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2337\/diacare.5.1.36","article-title":"Antibody response to pneumococcal polysaccharides in insulin-dependent diabetes mellitus","volume":"5","author":"Lederman","year":"1982","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127029_bb0230","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/dom.14643","article-title":"Humoral immune response to COVID-19 vaccination in diabetes is age-dependent but independent of type of diabetes and glycaemic control: the prospective COVAC-DM cohort study","volume":"24","author":"Sourij","year":"2022","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127029_bb0235","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ijo.2017.131","article-title":"Increased risk of influenza among vaccinated adults who are obese","volume":"41","author":"Neidich","year":"2017","journal-title":"Int J Obes"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127029_bb0240","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1002\/oby.20383","article-title":"Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza a virus","volume":"21","author":"Paich","year":"2013","journal-title":"Obesity"},{"issue":"20","key":"10.1016\/j.vaccine.2025.127029_bb0245","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1001\/archinte.160.20.3082","article-title":"A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women","volume":"160","author":"Baik","year":"2000","journal-title":"Arch Intern Med"},{"issue":"22","key":"10.1016\/j.vaccine.2025.127029_bb0250","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1001\/jama.1985.03360220053027","article-title":"Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine","volume":"254","author":"Weber","year":"1985","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127029_bb0255","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/08916930600597326","article-title":"Reduced tetanus antibody titers in overweight children","volume":"39","author":"Eliakim","year":"2006","journal-title":"Autoimmunity"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127029_bb0260","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.vaccine.2013.12.019","article-title":"Incidence and variables associated with inadequate antibody titers after pre-exposure rabies vaccination among veterinary medical students","volume":"32","author":"Banga","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127029_bb0265","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2337\/diab.46.5.887","article-title":"A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL\/6 (Akita) mutant mice","volume":"46","author":"Yoshioka","year":"1997","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127029_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2021.02.019","article-title":"Pleiotropic consequences of metabolic stress for the major histocompatibility complex class II molecule antigen processing and presentation machinery","volume":"54","author":"Clement","year":"2021","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127029_bb0275","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2016-000379","article-title":"Individuals with obesity and type 2 diabetes have additional immune dysfunction compared with obese individuals who are metabolically healthy","volume":"5","author":"Richard","year":"2017","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.vaccine.2025.127029_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2047-783X-15-S2-120","article-title":"Proinflammatory cytokines Il-6 and TNF-\u03b1 and the development of inflammation in obese subjects","volume":"15","author":"Popko","year":"2010","journal-title":"Eur J Med Res"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127029_bb0285","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/oby.2003.74","article-title":"Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression","volume":"11","author":"Bull\u00f3","year":"2003","journal-title":"Obes Res"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127029_bb0290","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/sj.ijo.0801792","article-title":"The relation of body fat mass and distribution to markers of chronic inflammation","volume":"25","author":"Festa","year":"2001","journal-title":"Int J Obes"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127029_bb0295","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.diabres.2004.11.007","article-title":"Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-\u03b1 and IL-6","volume":"69","author":"Park","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.vaccine.2025.127029_bb0300","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cyto.2016.06.028","article-title":"Adiponectin, TNF-\u03b1 and inflammatory cytokines and risk of type 2 diabetes: a systematic review and meta-analysis","volume":"86","author":"Liu","year":"2016","journal-title":"cytokine"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127029_bb0305","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/gene.2011.14","article-title":"State of the union between metabolism and the immune system in type 2 diabetes","volume":"12","author":"Nikolajczyk","year":"2011","journal-title":"Genes Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127029_bb0310","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/oby.21383","article-title":"Obesity decreases B cell responses in young and elderly individuals","volume":"24","author":"Frasca","year":"2016","journal-title":"Obesity"},{"key":"10.1016\/j.vaccine.2025.127029_bb0315","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.exger.2014.01.004","article-title":"High TNF-\u03b1 levels in resting B cells negatively correlate with their response","volume":"54","author":"Frasca","year":"2014","journal-title":"Exp Gerontol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127029_bb0320","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ajhb.21128","article-title":"Positive antibody response to vaccination in adolescence predicts lower C-reactive protein concentration in young adulthood in the Philippines","volume":"23","author":"McDade","year":"2011","journal-title":"Am J Hum Biol"},{"key":"10.1016\/j.vaccine.2025.127029_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12979-019-0164-9","article-title":"Immunosenescence and human vaccine immune responses","volume":"16","author":"Crooke","year":"2019","journal-title":"Immun Ageing"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127029_bb0330","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.2337\/dc12-0312","article-title":"Immune response of hepatitis B vaccine among persons with diabetes: a systematic review of the literature","volume":"35","author":"Schillie","year":"2012","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127029_bb0335","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1473-3099(10)70049-9","article-title":"The Xs and Y of immune responses to viral vaccines","volume":"10","author":"Klein","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"29\u201330","key":"10.1016\/j.vaccine.2025.127029_bb0340","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1016\/j.vaccine.2008.04.054","article-title":"Sexual dimorphism of humoral immunity with human vaccines","volume":"26","author":"Cook","year":"2008","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127029_bb0345","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"41","key":"10.1016\/j.vaccine.2025.127029_bb0350","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1016\/j.vaccine.2015.08.032","article-title":"Sex difference in immune response to vaccination: a participant-level meta-analysis of randomized trials of IMVAMUNE\u00ae smallpox vaccine","volume":"33","author":"Troy","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127029_bb0355","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1017\/S095026880100629X","article-title":"Immunogenicity and reactogenicity of the adult tetanus\u2013diphtheria vaccine. How many doses are necessary?","volume":"127","author":"Bayas","year":"2001","journal-title":"Epidemiol Infect"},{"issue":"25","key":"10.1016\/j.vaccine.2025.127029_bb0360","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1016\/j.vaccine.2007.04.017","article-title":"Comparative reactogenicity and immunogenicity of 23 valent pneumococcal vaccine administered by intramuscular or subcutaneous injection in elderly adults","volume":"25","author":"Cook","year":"2007","journal-title":"Vaccine"},{"issue":"25","key":"10.1016\/j.vaccine.2025.127029_bb0365","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2005.01.085","article-title":"Insufficient protection for healthy elderly adults by tetanus and TBE vaccines","volume":"23","author":"Hainz","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127029_bb0370","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s100960000305","article-title":"Effect on diphtheria immunity of combined tetanus and diphtheria booster vaccination in adults","volume":"19","author":"Marlovits","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127029_bb0375","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.vaccine.2004.07.024","article-title":"Persistence of antibody response to pneumococcal capsular polysaccharides in vaccinated long term-care residents in Brazil","volume":"23","author":"Brand\u00e3o","year":"2004","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127029_bb0380","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1086\/606046","article-title":"The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50\u201380 years","volume":"49","author":"Goldblatt","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127029_bb0385","article-title":"Hepatitis B vaccine: assessment of immunologic response, coverage rate, and factors influencing Seroreactivity2","volume":"7","author":"Khafagy","year":"2020","journal-title":"Clin Lab"},{"issue":"21","key":"10.1016\/j.vaccine.2025.127029_bb0390","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJM198605223142119","article-title":"Impaired immunogenicity of hepatitis B vaccine in obese persons","volume":"314","author":"Weber","year":"1986","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127029_bb0395","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/ijo.2011.208","article-title":"Obesity is associated with impaired immune response to influenza vaccination in humans","volume":"36","author":"Sheridan","year":"2012","journal-title":"Int J Obes"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127029_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100399","article-title":"Associations between serum cholesterol and immunophenotypical characteristics of circulatory B cells and Tregs","volume":"64","author":"Schmitz","year":"2023","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127029_bb0405","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.it.2021.11.007","article-title":"The cholesterol pathway: impact on immunity and cancer","volume":"43","author":"King","year":"2022","journal-title":"Trends Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127029_bb0410","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/CVI.13.2.165-169.2006","article-title":"Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines","volume":"13","author":"Romero-Steiner","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127029_bb0415","first-page":"51","article-title":"Immune responses to pneumococcal vaccines in children and adults: rationale for age-specific vaccination","volume":"3","author":"Westerink","year":"2012","journal-title":"Aging Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127029_bb0420","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s10156-013-0601-1","article-title":"Pneumococcal vaccine and opsonic pneumococcal antibody","volume":"19","author":"Song","year":"2013","journal-title":"J Infect Chemother"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127029_bb0425","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/ckj\/sfv030","article-title":"The ABC of pneumococcal infections and vaccination in patients with chronic kidney disease","volume":"8","author":"Vandecasteele","year":"2015","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127029_bb0430","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1128\/CVI.00735-14","article-title":"Use and clinical interpretation of pneumococcal antibody measurements in the evaluation of humoral immune function","volume":"22","author":"Daly","year":"2015","journal-title":"Clin Vaccine Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127029_bb0435","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1473-3099(14)70822-9","article-title":"Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study","volume":"14","author":"Andrews","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127029_bb0440","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1469-0691.2006.01677.x","article-title":"Dependence of correlations between antibody titres and opsonophagocytosis on pneumococcal serotype and patient morbidity in pre-and post-pneumococcal vaccination states","volume":"13","author":"Tarrag\u00f3","year":"2007","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127029_bb0445","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1128\/CVI.00654-15","article-title":"Poor correlation between pneumococcal IgG and IgM titers and opsonophagocytic activity in vaccinated patients with multiple myeloma and Waldenstrom's macroglobulinemia","volume":"23","author":"Karlsson","year":"2016","journal-title":"Clin Vaccine Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127029_bb0450","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/tri.12959","article-title":"Discrepant serological assays for pneumococcus in renal transplant recipients\u2013a prospective study","volume":"30","author":"Fishman","year":"2017","journal-title":"Transpl Int"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127029_bb0455","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1086\/374784","article-title":"Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients","volume":"187","author":"Kumar","year":"2003","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127029_bb0460","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4049\/jimmunol.1502136","article-title":"The emerging importance of IgG fab glycosylation in immunity","volume":"196","author":"van de Bovenkamp","year":"2016","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127029_bb0465","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1002\/jps.24444","article-title":"Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and fc-fusion proteins","volume":"104","author":"Liu","year":"2015","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2025.127029_bb0470","series-title":"The role of antibody glycosylation for antigen recognition and immunogenicity","author":"Wolf","year":"2021"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127029_bb0475","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/014860719101500160","article-title":"Nonenzymatic glycosylation of immunoglobulin G impairs complement fixation","volume":"15","author":"Hennessey","year":"1991","journal-title":"J Parenter Enter Nutr"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127029_bb0480","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/glycob\/cwz085","article-title":"On enzymatic remodeling of IgG glycosylation; unique tools with broad applications","volume":"30","author":"Sj\u00f6gren","year":"2020","journal-title":"Glycobiology"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127029_bb0485","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/s41590-023-01544-8","article-title":"Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapy","volume":"24","author":"Nimmerjahn","year":"2023","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127029_bb0490","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2249.1994.tb06133.x","article-title":"Glycation of monoclonal antibodies impairs their ability to bind antigen","volume":"98","author":"Kennedy","year":"1994","journal-title":"Clin Exp Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25003263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25003263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:07:39Z","timestamp":1762456059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25003263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":98,"alternative-id":["S0264410X25003263"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127029","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Humoral immune response to 10-valent pneumococcal conjugate vaccine (PCV10) in individuals with type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"127029"}}